Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis
,
*Department of Cardiological Sciences, St George's Hospital Medical School London, UK
Division of Cardiology, Department of Clinical and Experimental Medicine, Padua University Italy
CNR Unit for Muscle Biology and Physiopathology, Department of Experimental and Biomedical Sciences, University of Padua Italy
revised 20 May 1996; accepted 29 May 1996.
Correspondence: Ahda L. P. Caforio, MD, PhD, FESC, Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 ORE, U.K.
Abstract
AIM: Myocarditis and dilated cardiomyopathy may be phases of an organ-specific autoimmune disease of the myocardium. To provide evidence for autoimmune involvement in myocarditis, cardiac autoantibodies were detected in patient sera from the Myocarditis Treatment Trial.
METHODS AND RESULTS: Cardiac antibody status was assessed by indirect immunofluorescence and by anti-
-myosin enzyme-linked inimunosorbent assay in 53 patients from the Myocarditis Treatment Trial (35 males, aged 42±15 years); all had clinical myocarditis, but only 24 were classified as having histological myocarditis (Dallas criteria). By immunofluorescence, cardiac antibodies were more common in myocarditis (13/53) than in ischaemic (11/186, P=0·0001) or in normal controls (24/270, P=0·001). Abnormally raised anti--myosin antibodies were also more frequent in myocarditis (9/53) than in ischaemic (4/92, P0·01) or normal controls (4/203, P=0·0001); 34% of myocarditis patients were positive with one or both tests. Similar proportions of patients with and without histological myocarditis had antibodies by immunofluorescence (8/24 vs 5/29, P=ns) and by enzyme-linked immunosorbent assay (4/24 vs 5/29, P=ns).
CONCLUSION: The detection of disease-specific cardiac autoantibodies supports autoimmune involvement in a subset of patients with clinical myocarditis. The lack of correlation of antibody with biopsy features suggests that diagnosis of myocarditis should not be made on histology alone. Autoimmune markers may provide adjunct diagnostic tools and identify patients in whom immunosuppression is of potential benefit.
Key Words: Myocarditis • autoimmunity • myosin • cardiac autoantibodies
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. U. Knowlton and B.-K. Lim Viral myocarditis is infection of the heart required? J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1227 - 1228. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dennert, H. J. Crijns, and S. Heymans Acute viral myocarditis Eur. Heart J., September 1, 2008; 29(17): 2073 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L.P. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis Eur. Heart J., June 1, 2007; 28(11): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Lewis, C. B. Holmes, G. Holmvang, and J. R. Butterton Case 8-2007 -- A 48-Year-Old Man with Chest Pain Followed by Cardiac Arrest N. Engl. J. Med., March 15, 2007; 356(11): 1153 - 1162. [Full Text] [PDF]
|
|
|
|
 |
|
 A L. Caforio, L Daliento, A Angelini, S Bottaro, A Vinci, G Dequal, F Tona, S Iliceto, G Thiene, and W J McKenna Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies Lupus, September 1, 2005; 14(9): 652 - 655. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L. Guler, D. L. Ligons, Y. Wang, M. Bianco, K. W. Broman, and N. R. Rose Two Autoimmune Diabetes Loci Influencing T Cell Apoptosis Control Susceptibility to Experimental Autoimmune Myocarditis J. Immunol., February 15, 2005; 174(4): 2167 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lowenstein Exogenous Thioredoxin Reduces Inflammation in Autoimmune Myocarditis Circulation, September 7, 2004; 110(10): 1178 - 1179. [Full Text] [PDF]
|
|
|
|
 |
|
 A. L.P. Caforio, N. J. Mahon, F. Tona, and W. J. McKenna Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance Eur J Heart Fail, August 1, 2002; 4(4): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Afanasyeva, Y. Wang, Z. Kaya, E. A. Stafford, K. M. Dohmen, A. A. Sadighi Akha, and N. R. Rose Interleukin-12 Receptor/STAT4 Signaling Is Required for the Development of Autoimmune Myocarditis in Mice by an Interferon-{gamma}-Independent Pathway Circulation, December 18, 2001; 104(25): 3145 - 3151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Liu and J. W. Mason Advances in the Understanding of Myocarditis Circulation, August 28, 2001; 104(9): 1076 - 1082. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Godsel, K. Wang, B. A. Schodin, J. S. Leon, S. D. Miller, and D. M. Engman Prevention of Autoimmune Myocarditis Through the Induction of Antigen-Specific Peripheral Immune Tolerance Circulation, March 27, 2001; 103(12): 1709 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Malkiel, L. Liao, M. W. Cunningham, and B. Diamond T-Cell-Dependent Antibody Response to the Dominant Epitope of Streptococcal Polysaccharide, N-Acetyl-Glucosamine, Is Cross-Reactive with Cardiac Myosin Infect. Immun., October 1, 2000; 68(10): 5803 - 5808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lauer, M. Schannwell, U. Kuhl, B.-E. Strauer, and H.-P. Schultheiss Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis J. Am. Coll. Cardiol., January 1, 2000; 35(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|